Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Buy
1,990
+138
+7% +$25.4K 0.15% 162
2025
Q4
$350K Buy
1,852
+92
+5% +$15K 0.15% 153
2025
Q3
$247K Buy
+1,760
New +$238K 0.12% 201

Other funds holding BIIB

QTR Family Wealth's BIIB Position: Q1 2026 in Review

QTR Family Wealth increased its Biogen (BIIB) stake by 7.5% in Q1 2026, buying an estimated $25.4K and bringing the position to 1,990 shares worth $356K. The position accounts for 0.15% of the portfolio, ranked #162.

QTR Family Wealth first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • QTR Family Wealth held 1,990 shares of Biogen worth $356K as of Q1 2026.
  • QTR Family Wealth bought 138 Biogen shares in Q1 2026, an estimated $25.4K.
  • Biogen made up 0.15% of QTR Family Wealth's portfolio in Q1 2026, its #162 holding.
  • QTR Family Wealth first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on QTR Family Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.